$AREN
Arena Group Holdings, Inc.

2013 Q4 Form 10-Q Financial Statement

#000114420413061595 Filed on November 14, 2013

View on sec.gov

Income Statement

Concept 2013 Q4 2013 Q3 2012 Q4
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $60.00K $50.00K $50.00K
YoY Change 20.0% 0.0% 0.0%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $60.00K $50.00K $50.00K
YoY Change 20.0% 0.0% 0.0%
Operating Profit -$54.83K
YoY Change
Interest Expense $10.00K $0.00 -$10.00K
YoY Change -200.0% -100.0% 0.0%
% of Operating Profit
Other Income/Expense, Net -$2.538K
YoY Change
Pretax Income -$50.00K -$57.36K -$50.00K
YoY Change 0.0% 64.49% -16.67%
Income Tax $0.00 $0.00 -$10.00K
% Of Pretax Income
Net Earnings -$50.00K -$57.36K -$50.00K
YoY Change 0.0% 64.49% -16.67%
Net Earnings / Revenue
Basic Earnings Per Share $0.00
Diluted Earnings Per Share -$0.13 $0.00 -$0.12
COMMON SHARES
Basic Shares Outstanding 8.650M shares 8.548M shares
Diluted Shares Outstanding 8.548M shares

Balance Sheet

Concept 2013 Q4 2013 Q3 2012 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.600M $2.700M $2.800M
YoY Change -7.14% -3.57% -3.45%
Cash & Equivalents $99.72K $71.41K $114.0K
Short-Term Investments $2.500M $2.600M $2.700M
Other Short-Term Assets $32.05K $41.12K $36.33K
YoY Change -11.77% 66.14%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $2.658M $2.694M $2.809M
YoY Change -5.35% -7.11% -4.36%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $0.00
YoY Change -100.0%
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00 $0.00
YoY Change -100.0%
TOTAL ASSETS
Total Short-Term Assets $2.658M $2.694M $2.809M
Total Long-Term Assets $0.00 $0.00 $0.00
Total Assets $2.658M $2.694M $2.809M
YoY Change -5.35% -7.11% -28.66%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $18.00K $11.00K $0.00
YoY Change -100.0%
Accrued Expenses $0.00 $0.00 $0.00
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $94.24K $82.88K $125.1K
YoY Change -24.7% -58.56% 22.48%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $94.24K $82.88K $125.1K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $100.0K $100.0K $100.0K
YoY Change 0.0% -50.0% 0.0%
SHAREHOLDERS EQUITY
Retained Earnings -$62.09M -$62.04M -$61.92M
YoY Change 0.29% 2.04%
Common Stock $86.50K $85.61K $83.18K
YoY Change 4.0% 3.6%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $2.396M $2.442M $2.515M
YoY Change
Total Liabilities & Shareholders Equity $2.658M $2.694M $2.809M
YoY Change -5.35% -7.11% -28.66%

Cashflow Statement

Concept 2013 Q4 2013 Q3 2012 Q4
OPERATING ACTIVITIES
Net Income -$50.00K -$57.36K -$50.00K
YoY Change 0.0% 64.49% -16.67%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$30.00K -$50.00K -$40.00K
YoY Change -25.0% 25.0% 33.33%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $60.00K $20.00K -$650.0K
YoY Change -109.23% -96.67% 103.13%
Cash From Investing Activities $60.00K $20.00K -$650.0K
YoY Change -109.23% -96.67% 103.13%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities -30.00K -50.00K -40.00K
Cash From Investing Activities 60.00K 20.00K -650.0K
Cash From Financing Activities
Net Change In Cash 30.00K -30.00K -690.0K
YoY Change -104.35% -105.36% 97.14%
FREE CASH FLOW
Cash From Operating Activities -$30.00K -$50.00K -$40.00K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2012Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
15625 USD
CY2013Q3 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
0 USD
CY2012Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
682 USD
CY2013Q3 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
71884 USD
CY2012Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
108839 USD
CY2013Q3 us-gaap Liabilities Current
LiabilitiesCurrent
82884 USD
CY2012Q4 us-gaap Liabilities Current
LiabilitiesCurrent
125146 USD
CY2013Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
dei Trading Symbol
TradingSymbol
ISSM
CY2013Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
8650417 shares
dei Entity Registrant Name
EntityRegistrantName
INTEGRATED SURGICAL SYSTEMS INC
dei Entity Central Index Key
EntityCentralIndexKey
0000894871
CY2012Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2013Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2012Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2013Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
8561131 shares
CY2012Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
8318073 shares
CY2013Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
71413 USD
CY2013Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
0 USD
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
CY2013Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
dei Document Type
DocumentType
10-Q
dei Amendment Flag
AmendmentFlag
false
dei Document Period End Date
DocumentPeriodEndDate
2013-09-30
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2013
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
68840 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-123233 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
800 USD
us-gaap Net Income Loss
NetIncomeLoss
-124033 USD
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8469173 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
8469173 shares
CY2012Q4 us-gaap Other Assets Current
OtherAssetsCurrent
36331 USD
CY2012Q4 us-gaap Assets Current
AssetsCurrent
2808512 USD
CY2012Q4 us-gaap Assets
Assets
2808512 USD
CY2012Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
0 USD
CY2013Q3 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
2581268 USD
CY2012Q4 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
2658190 USD
CY2013Q3 us-gaap Other Assets Current
OtherAssetsCurrent
41123 USD
CY2013Q3 us-gaap Assets Current
AssetsCurrent
2693804 USD
CY2013Q3 us-gaap Assets
Assets
2693804 USD
CY2013Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
11000 USD
CY2012Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
8318073 shares
CY2013Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
8561131 shares
CY2013Q3 issm Common Stock Value To Be Issued
CommonStockValueToBeIssued
12500 USD
CY2012Q4 issm Common Stock Value To Be Issued
CommonStockValueToBeIssued
0 USD
CY2013Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
64393477 USD
CY2012Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
64352158 USD
CY2013Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-62041335 USD
CY2012Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-61917302 USD
CY2013Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-7829 USD
CY2012Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-3166 USD
CY2013Q3 us-gaap Stockholders Equity
StockholdersEquity
2442424 USD
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
2514870 USD
CY2013Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2693804 USD
CY2012Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2808512 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
202220 USD
us-gaap Cost Method Investments Realized Gain Loss
CostMethodInvestmentsRealizedGainLoss
0 USD
us-gaap Cost Method Investments Realized Gain Loss
CostMethodInvestmentsRealizedGainLoss
811713 USD
us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
-3419 USD
us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
-1231 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
623386 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
8013 USD
us-gaap Net Income Loss
NetIncomeLoss
615373 USD
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-4663 USD
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
6737 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-128696 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
622110 USD
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.08
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.07
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
113991 USD
CY2012Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2013Q3 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
168496 USD
CY2012Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
168496 USD
CY2013Q3 us-gaap Common Stock Value
CommonStockValue
85611 USD
CY2012Q4 us-gaap Common Stock Value
CommonStockValue
83180 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
203189 USD
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8155137 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9146290 shares
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
379813 USD
issm Stock To Be Issued During Period Value Common Stock
StockToBeIssuedDuringPeriodValueCommonStock
12500 USD
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
422984 USD
CY2012Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
802797 USD
CY2013Q3 us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
-14511 USD
CY2012Q3 us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
-89 USD
CY2013Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-57363 USD
CY2012Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-34873 USD
CY2013Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2012Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2013Q3 us-gaap Net Income Loss
NetIncomeLoss
-57363 USD
CY2012Q3 us-gaap Net Income Loss
NetIncomeLoss
-34873 USD
CY2013Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
21063 USD
CY2012Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-5580 USD
CY2013Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-36300 USD
CY2012Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-40453 USD
CY2013Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2012Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2013Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2012Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2013Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8548393 shares
CY2012Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8229757 shares
CY2013Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
8548393 shares
CY2012Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
8229757 shares
us-gaap Share Based Compensation
ShareBasedCompensation
40625 USD
us-gaap Share Based Compensation
ShareBasedCompensation
46875 USD
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
4792 USD
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
5228 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
11000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
8500 USD
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-682 USD
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
7213 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-111418 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-104831 USD
us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
1478303 USD
us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
1492106 USD
us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
240633 USD
us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
0 USD
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
1306510 USD
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
1976750 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
484644 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-42578 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
2800 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
800 USD
issm Supplemental Gains Losses Unrealized Securities Net Of Taxes
SupplementalGainsLossesUnrealizedSecuritiesNetOfTaxes
-4663 USD
issm Supplemental Gains Losses Unrealized Securities Net Of Taxes
SupplementalGainsLossesUnrealizedSecuritiesNetOfTaxes
6737 USD
issm Dividend Of Investment
DividendOfInvestment
0 USD
issm Dividend Of Investment
DividendOfInvestment
1803808 USD
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
43750 USD
us-gaap Nature Of Operations
NatureOfOperations
<div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="clear:both;FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman,serif; MARGIN: 0in 0in 0pt"> <b><font style="FONT-SIZE: 10pt">1. Organization and Operations</font></b></div> <div style="clear:both;FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman,serif; MARGIN: 0in 0in 0pt; TEXT-INDENT: 0.5in"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both;FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman,serif; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">Integrated Surgical Systems, Inc. (the &#8220;Company&#8221;) was incorporated in Delaware in 1990 to design, manufacture, sell and service image-directed, computer-controlled robotic software and hardware products for use in orthopedic surgical procedures.&#160;&#160;On June 28, 2007, the Company completed the sale of substantially all of its operating assets.&#160;&#160;After completion of the sale, the Company no longer engaged in any business activities related to its former business described above. The Company&#8217;s current operations are limited to raising additional funds to be used to maintain the Company&#8217;s public company status and to complete a business combination or strategic alliance, if suitable candidates are identified.</font></div> </div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2013Q3 issm Available For Sale Securities Debt Maturities After One Through Three Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsAmortizedCost
1045080 USD
CY2013Q3 issm Available For Sale Securities Debt Maturities After Three Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterThreeYearsAmortizedCost
1015902 USD
us-gaap Use Of Estimates
UseOfEstimates
<div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="clear:both;FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman,serif; MARGIN: 0in 0in 0pt" align="justify"><i><font style="FONT-SIZE: 10pt">Use of Estimates</font></i></div> <div style="clear:both;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt; FONT-FAMILY: Times New Roman,serif; FONT-SIZE: 12pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both;MARGIN: 0in 0in 0pt; FONT-FAMILY: Times New Roman,serif; FONT-SIZE: 12pt" align="justify"><font style="FONT-SIZE: 10pt">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and revenues and expenses for the reporting period.&#160;&#160;Actual results could differ from those estimates.</font></div> <div style="clear:both;MARGIN: 0in 0in 0pt; FONT-FAMILY: Times New Roman,serif; FONT-SIZE: 12pt" align="justify">&#160;</div> </div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2013Q3 issm Checking Account
CheckingAccount
22000 USD
CY2013Q3 issm Assets Guaranteed By Fdic Maximum
AssetsGuaranteedByFdicMaximum
250000 USD
CY2013Q3 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
50000 USD
CY2013Q3 issm Maximum Amount Of Assets Protected By Securities Investor Protection Corporation In Brokerage Account
MaximumAmountOfAssetsProtectedBySecuritiesInvestorProtectionCorporationInBrokerageAccount
500000 USD
CY2013Q3 us-gaap Available For Sale Securities Debt Maturities Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAmortizedCost
2589097 USD
CY2013Q3 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
528115 USD
CY2013Q3 us-gaap Equity Method Investment Ownership Percentage
EquityMethodInvestmentOwnershipPercentage
0.2 pure
us-gaap Incremental Common Shares Attributable To Conversion Of Preferred Stock
IncrementalCommonSharesAttributableToConversionOfPreferredStock
1158845 shares
CY2013Q3 us-gaap Incremental Common Shares Attributable To Conversion Of Preferred Stock
IncrementalCommonSharesAttributableToConversionOfPreferredStock
1217457 shares
issm Gain On Incremental Common Shares Attributable To Dilutive Effect Of Conversion Of Preferred Stock
GainOnIncrementalCommonSharesAttributableToDilutiveEffectOfConversionOfPreferredStock
991153 shares
CY2012Q3 issm Gain On Incremental Common Shares Attributable To Dilutive Effect Of Conversion Of Preferred Stock
GainOnIncrementalCommonSharesAttributableToDilutiveEffectOfConversionOfPreferredStock
991153 shares
us-gaap Gain Loss On Investments
GainLossOnInvestments
3419 USD
CY2013Q3 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
2589097 USD
us-gaap Available For Sale Securities Gross Unrealized Gains
AvailableForSaleSecuritiesGrossUnrealizedGains
15882 USD
us-gaap Available For Sale Securities Gross Unrealized Loss
AvailableForSaleSecuritiesGrossUnrealizedLoss
-23711 USD
CY2013Q3 us-gaap Available For Sale Securities
AvailableForSaleSecurities
2581268 USD
CY2012Q4 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
2661356 USD
CY2012 us-gaap Available For Sale Securities Gross Unrealized Gains
AvailableForSaleSecuritiesGrossUnrealizedGains
25461 USD
CY2012Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
2658190 USD
CY2012 us-gaap Available For Sale Securities Gross Unrealized Loss
AvailableForSaleSecuritiesGrossUnrealizedLoss
-28627 USD
CY2013Q3 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
526184 USD
CY2013Q3 issm Available For Sale Securities Debt Maturities After One Through Three Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue
1042919 USD
CY2013Q3 issm Available For Sale Securities Debt Maturities After Three Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterThreeYearsFairValue
1012165 USD
CY2013Q3 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
89286 shares
CY2013Q3 issm Stock Issued During Period Per Share Value Of New Issues
StockIssuedDuringPeriodPerShareValueOfNewIssues
0.14
CY2013Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
12500 USD
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
100000 shares
CY2011Q2 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
1.25 pure
CY2013Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
30000 shares
CY2013Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights
0.63
CY2013Q2 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
78126 shares
CY2012Q4 issm Stock Issued During Period Per Share Value Of New Issues
StockIssuedDuringPeriodPerShareValueOfNewIssues
0.20
CY2012Q4 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
15625 USD
CY2013Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
86806 shares
CY2013Q1 issm Stock Issued During Period Per Share Value Of New Issues
StockIssuedDuringPeriodPerShareValueOfNewIssues
0.18
CY2013Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
15625 USD
CY2012Q4 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
78126 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
100000 shares
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0 shares
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
0 shares
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
0
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P0Y
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P0Y

Files In Submission

Name View Source Status
0001144204-13-061595-index-headers.html Edgar Link pending
0001144204-13-061595-index.html Edgar Link pending
0001144204-13-061595.txt Edgar Link pending
0001144204-13-061595-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
issm-20130930.xml Edgar Link completed
issm-20130930.xsd Edgar Link pending
issm-20130930_cal.xml Edgar Link unprocessable
issm-20130930_def.xml Edgar Link unprocessable
issm-20130930_lab.xml Edgar Link unprocessable
issm-20130930_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
v359316_10q.htm Edgar Link pending
v359316_ex31-1.htm Edgar Link pending
v359316_ex31-2.htm Edgar Link pending
v359316_ex32-1.htm Edgar Link pending
v359316_ex32-2.htm Edgar Link pending